Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Novel Abeta peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease.
Zhou J, Fonseca MI, Kayed R, Hernandez I, Webster SD, Yazan O, Cribbs DH, Glabe CG, Tenner AJ
J Neuroinflammation 2005, 2:28
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research    
Reduction of -amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
Paris D, Ganey NJ, Laporte V, Patel NS, Beaulieu-Abdelahad D, Bachmeier C, March A, Ait-Ghezala G, Mullan MJ
Journal of Neuroinflammation 2010, 7:17 (8 March 2010)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
2.


Research    
Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following A immunotherapy
Das P, Smithson LA, Price RW, Holloway VM, Levites Y, Chakrabarty P, Golde TE
Journal of Neuroinflammation 2006, 3:17 (26 July 2006)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
3.


Research    
Boosting with intranasal dendrimeric A115 but not A115 peptide leads to an effective immune response following a single injection of A140/42 in APP-tg mice
Seabrook TJ, Jiang L, Thomas K, Lemere CA
Journal of Neuroinflammation 2006, 3:14 (5 June 2006)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]

This article is also cited by a further 8 articles in PubMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.